389 related articles for article (PubMed ID: 21515329)
1. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study.
Kotan VO; Sarandol E; Kirhan E; Ozkaya G; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1284-90. PubMed ID: 21515329
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479
[TBL] [Abstract][Full Text] [Related]
3. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems.
Sarandol A; Sarandol E; Eker SS; Erdinc S; Vatansever E; Kirli S
Hum Psychopharmacol; 2007 Mar; 22(2):67-73. PubMed ID: 17299810
[TBL] [Abstract][Full Text] [Related]
4. Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.
Sarandol A; Kirli S; Akkaya C; Altin A; Demirci M; Sarandol E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1164-9. PubMed ID: 17459548
[TBL] [Abstract][Full Text] [Related]
5. First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment.
Sarandol A; Sarandol E; Acikgoz HE; Eker SS; Akkaya C; Dirican M
Psychiatry Clin Neurosci; 2015 Nov; 69(11):699-707. PubMed ID: 26172069
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment.
Sarandol A; Kirli S; Akkaya C; Ocak N; Eroz E; Sarandol E
J Psychopharmacol; 2007 Nov; 21(8):857-63. PubMed ID: 17715203
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
[TBL] [Abstract][Full Text] [Related]
8. Lipid peroxidation markers in adult attention deficit hyperactivity disorder: new findings for oxidative stress.
Bulut M; Selek S; Bez Y; Cemal Kaya M; Gunes M; Karababa F; Celik H; Savas HA
Psychiatry Res; 2013 Oct; 209(3):638-42. PubMed ID: 23680468
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
10. Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia.
Sarandöl E; Safak O; Dirican M; Uncu G
Clin Biochem; 2004 Nov; 37(11):990-6. PubMed ID: 15498527
[TBL] [Abstract][Full Text] [Related]
11. Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease.
Serdar Z; Yeşilbursa D; Dirican M; Sarandöl E; Serdar A
Cell Biochem Funct; 2007; 25(6):655-64. PubMed ID: 17006879
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.
Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A
Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350
[TBL] [Abstract][Full Text] [Related]
13. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment.
Baskol G; Atmaca H; Tanriverdi F; Baskol M; Kocer D; Bayram F
Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):522-6. PubMed ID: 17853336
[TBL] [Abstract][Full Text] [Related]
15. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
16. Influence of therapy on the antioxidant status in patients with melanoma.
Gadjeva V; Dimov A; Georgieva N
J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
[TBL] [Abstract][Full Text] [Related]
17. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase activity in glomerulonephritic patients.
Gullulu M; Kahvecioglu S; Dirican M; Akdag I; Ocak N; Demircan C; Dilek K; Ersoy A; Yavuz M; Yurtkuran M
Ren Fail; 2007; 29(4):433-9. PubMed ID: 17497465
[TBL] [Abstract][Full Text] [Related]
19. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease.
Lee BJ; Huang YC; Chen SJ; Lin PT
Nutrition; 2012 Mar; 28(3):250-5. PubMed ID: 21996047
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
